BIOASTER receives from Sanofi Pasteur a donation to contribute, in addition to the local authorities, to the funding of its new building within the campus of BioDistrict Lyon
With a donation of € 1 million, Sanofi Pasteur strengthens the support of the
Rhône-Alpes region and the Metropolis of Lyon, which co-fund the building for a total amount of € 10.5 million.
Lyon, June 1st, 2015 - BIOASTER microbiology technological institute announced today that it will receive from Sanofi Pasteur, a donation of €1 million for its BIOASTER1 building, currently under construction at 40 Avenue Tony Garnier in BioDistrict Lyon campus, the heart of life sciences in Lyon. This donation supplements the financial support of the local authorities, Rhône-Alpes region and The Metropolis of Lyon which co-fund 40 % of the project. By doing so, Sanofi Pasteur, one of the industrial founders of BIOASTER, strengthens its commitment to the IRT, and the development and growth of the BioDistrict campus which already hosts several pillars of Sanofi Group: Sanofi, Merial, Genzyme, Sanofi Pasteur and soon the consolidated world headquarters of the two entities Merial and Sanofi Pasteur. É DE PRESSE 1/3 É DE PRESSE The new building will host BIOASTER teams by mid-2015. This center for innovation will represent 3,800 m2, including 2,200 m2 of P1, P2 and P3 laboratories to accommodate collaborative projects
IQU between BIOASTER, academic and industrial research teams (large groups and SMEs). Pascale Boissel, Deputy Executive Officer & Chief Financial Officer of BIOASTER emphasises: "This new building will be one of the key player within BioDistrict Lyon, whose development is strongly supported by the Rhône-Alpes region and the Metropolis of Lyon. It has been designed to be a home for projects, accommodating multidisciplinary teams and partners for the development of MMUN programmes of excellence in the field of infectious diseases and microbiology. This new building
O space is designed to stimulate the collaboration amongst research teams in an environment at the
C forefront of technology. Sanofi Pasteur support is a strong signal of industry support to this
| ambitious assembly of actors from different horizons under common projects”.
Biodistrict Lyon Coordinated by the Metropolis of Lyon, the Biodistrict Lyon’s dynamic ambitions to position Lyon among the major sites for biotechnologies and health in the world. LEASE Biodistrict Lyon proposes a coherent, visible and attractive territorial economic offer to support the development and setting-up of economic activities and innovation in life sciences. RE Already endowed with an exceptional critical mass of players, the Biodistrict Lyon follows the goal to welcome new ones in the coming years: - Research centers on themes of disruptive innovation; - World-famous experts; RESS
P BIOASTER - Bâtiment Domilyon - 321, avenue Jean-Jaurès - 69007 Lyon - France - Tel: +33 (0)4 69 84 26 00 - www.bioaster.org
- A leading company of the therapeutic sector; - 50 to 100 SMEs developing innovative products and services; - State to the art equipments and platforms; - A complete and diversified network of Life sciences advisors (legal, investment, IP, HR, QC, …). *** About BIOASTER
BIOASTER is a technology institute that leads research programs in four major application fields in health-related microbiology and infectious diseases: vaccines, antimicrobials, diagnosis and microbiota. BIOASTER implements transdisciplinary R&D programs that bring together academics, small and medium-sized enterprises and industrials around thematic and technology units. Each project is undertaken by a team of high-level scientists and engineers that benefits from state-of- the-art equipment, technological infrastructures and academic research excellence. Teams are led by managers who are wellversed in the industrial standards, as well as from partnerships carefully developed for conducting breakthrough innovations. BIOASTER, an independent non-profit organization, is one of eight French TRIs (Technology Research Institutes). It was created in 2012 at the initiative of Lyonbiopôle and the Institut Pasteur in Paris. It was founded by CNRS, INSERM, the CEA, Mérieux Institute, Danone Research and Sanofi Pasteur and is supported by 40 SMEs in the Lyon and Paris regions as well as the French government, through the Investments for the future program for the Grand Lyon la métropole and the Rhône-Alpes region. Benefiting from two different locations in Lyon and Paris, BIOASTER has a staff of an hundred people, including more than 70 scientists and engineers, from 16 different nationalities. For more information: www.bioaster.org
About Sanofi Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). COMMUNIQUÉ DE PRESSE 2/3 COMMUNIQUÉ DE PRESSE
| Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers a broad range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information: www.sanofipasteur.com or www.sanofipasteur.us.
PRESS RELEASE RELEASE PRESS BIOASTER - Bâtiment Domilyon - 321, avenue Jean-Jaurès - 69007 Lyon - France - Tel: +33 (0)4 69 84 26 00 - www.bioaster.org
About Métropole de Lyon The Metropolis of Lyon (Métropole de Lyon) is a new type of French local authority, created on January 1st, 2015, merging former public policies and responsibilities of the Urban Community of Lyon ("Greater Lyon", created by law in 1966) and the Rhône department. "La Métropole de Lyon" is a political and administrative institution in charge of urban services and development on a territory of 59 municipalities representing 1.3 million inhabitants and 52.500 hectares. The metropolitan council is composed of 166 elected officials. The President of the Métropole is Mr
Gerard Collomb, also Mayor of Lyon. For more information: http://www.grandlyon.com
About Rhône-Alpes Region Rhône-Alpes Region supports research and innovation and devote about 120 M€ per year for higher education, advanced research and innovation. In its drive to forge new pathways, Rhône-Alpes encourages the creation of synergies with other areas of technological excellence. By combining biotechnologies, micro and nano-technologies, “green techs”, traditional industries, the region is a hotbed for the creation of new therapeutic methods, healthcare techniques and innovative products. Regional Innovation Strategy – Smart Specialisation (RIS3), an ex-ante condition to receive European structural funds, sustains 3 goals: improve the regional innovation system, enlarge innovation’s fields of and develop our smart specialization areas. Until 2020, one billion Euros will be dedicated to the development of RIS3 in Rhône-Alpes. The smart specialization area on personalized healthcare for infectious and chronic diseases reposes on a wide range of differentiating and unique assets. Key Facts: - France’s n°.2 employer in health industries with 30 000 employments - 6 500 researchers and 20 000 students in life sciences - 2 world class clusters : Lyonbiopole (healthcare innovation) and Minalogic (Digital, Micro nanoelectronics, Software) For more information: http://en.rhonealpes.fr/
COMMUNIQUÉ DE PRESSE 3/3 COMMUNIQUÉ DE PRESSE Press contacts
| BIOASTER SANOFI PASTEUR ATCG Partners Relations Presse Marie Puvieux: +33 (0)6 10 54 36 72 Alain Bernal : +33 (0)4 37 37 50 38 [email protected] [email protected]
PRESS RELEASE RELEASE PRESS BIOASTER - Bâtiment Domilyon - 321, avenue Jean-Jaurès - 69007 Lyon - France - Tel: +33 (0)4 69 84 26 00 - www.bioaster.org